Peer-reviewed veterinary case report
Preventing malignant hyperthermia return with propofol anesthesia
By Kudo, Ayano et al.·Published in Veterinary anaesthesia and analgesia·2026·School of Veterinary Medicine, Japan·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Use of total intravenous anesthesia with propofol and a vaporizer-free ventilator to prevent recurrence of malignant hyperthermia in a dog.
- Species:
- dog
Plain-English summary
A 13-year-old spayed female Toy Poodle was brought in for an oral examination and biopsy of a tongue mass. She had a history of malignant hyperthermia (MH), a dangerous reaction to certain anesthetics, which had occurred four years earlier. To prevent this from happening again, the veterinary team used total intravenous anesthesia (TIVA) with propofol and a special ventilator that didn't use inhalant anesthetics. The procedure went smoothly, her temperature remained stable, and she recovered well without needing additional medication. This approach appears to be a safe option for dogs at risk of MH.
People also search for: Toy Poodle anesthesia risks · malignant hyperthermia in dogs · propofol anesthesia for dogs · dog tongue mass biopsy recovery
Abstract
Malignant hyperthermia (MH) is a rare, life-threatening perioperative complication most commonly triggered by inhalant anesthetics or depolarizing neuromuscular blocking agents. Genetic variants affecting skeletal muscle are believed to underlie the susceptibility to MH. Although total intravenous anesthesia (TIVA) has been employed in human patients with MH susceptibility as a nontriggering alternative, comparable data and standardized protocols are limited in veterinary medicine. A 13-year-old spayed female Toy Poodle dog with a history of suspected MH during isoflurane anesthesia 4 years earlier, characterized by a rapid increase in body temperature (42.0 °C) and end-tidal carbon dioxide tension (PE´CO), and successfully treated with active cooling and dantrolene administration, presented for treatment of an asymptomatic tongue mass. General anesthesia was planned to facilitate a thorough oral examination and biopsy. TIVA with propofol was performed to prevent MH recurrence, using a vaporizer-free ventilator. Following anesthetic premedication with buprenorphine (20 μg kg, intravenously) and atropine sulfate (25 μg kg, subcutaneously), anesthesia was induced with propofol to allow endotracheal intubation and maintained with a propofol variable rate intravenous infusion (0.4-0.5 mg kgminute) under mechanical ventilation with 100% oxygen. Dantrolene was available but was not required. During the 37-minute anesthetic period, rectal temperature gradually decreased, and PE´COremained stable. Inspired isoflurane fraction was undetectable during the perioperative period. Recovery was smooth, and postoperative blood tests revealed only mild creatine kinase elevation. Whole-genome sequencing of peripheral blood DNA revealed a missense variant in the ryanodine receptor gene (RYR1), identical to a known human MH-causing mutation (p.Arg2435His). This case suggests that propofol-based TIVA combined with a vaporizer-free ventilator can safely prevent MH recurrence in genetically susceptible dogs, highlighting the importance of eliminating all potential MH triggers in susceptible individuals.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/41962260/